Re: ANPA egroup: Medicine in India: Rampant Quackery, Baffling Drug Landscape Adedeji Adefuye 23 Aug 2015 22:41 CDT

Thanks Ben for sharing this insightful study.
Our colleagues and friends in Nigeria sure need to read this. I have shared with those in my network in Nigeria and would suggest as many of us as possible on this listserv do same.

Deji

Adedeji Adefuye, MD, MPH, FRIPH, FRSPH

If you are planning for tomorrow, sow rice; if you are planning for a decade, plant trees; if you are planning for a life time, educate people - Chinese proverb.

--------------------------------------------
On Sun, 8/23/15, Ben Nwomeh <bnwomeh@gmail.com> wrote:

 Subject: ANPA egroup: Medicine in India: Rampant Quackery, Baffling Drug Landscape
 To: "egroup" <egroup@anpa.org>
 Date: Sunday, August 23, 2015, 7:49 PM

 Cautionary tale that
 places Nigeria's $500 billion/year patronage in
 perspective.....

 Ben Nwomeh, MD, MPH

 	Medicine in India: Rampant Quackery, Baffling Drug
 Landscape

 		By
 Frederik Joelving,
 www.medpagetoday.com
 		View
 Original

 NEW DELHI -- Everything about 33-year-old Vishal
 Chand pointed to a myocardial infarction when he presented
 to Tata Main
 Hospital in Jamshedpur, India, with chest pain.
 His heart activity was so erratic that his ECG would
 have looked "abnormal even to a layman," one
 doctor later testified. But
  instead of admitting Chand, the emergency physician at Tata
 Main sent
 him home with drugs for pain, heartburn, and anxiety. Chand
 died the
 next day.

 Medical errors happen everywhere. But in the world's
 largest democracy, stories of doctors being drunk, using
 rusty
 instruments or bicycle pumps during surgery, or ordering
 unjustified
 procedures are increasingly common.
 Now hard data are emerging that show how dismal
 medical care is for many in India, with providers routinely
 failing to
 diagnose common diseases and frequently prescribing useless
 and
 hazardous drugs.
 In North India, for example, the chances of getting a
  helpful prescription at the doctor's office are no
 better than a coin
 toss, while "you have about an 80% chance of getting
 stuff you don't
 need," estimates Jishnu Das, PhD, a lead economist at
 the World Bank in
 Washington, D.C., who has been studying India's
 healthcare sector for
 years.

 'Qualified Quacks'

 Consider heart attack, a major killer in India. Using
  actors trained to fake chest pain and other classic
 symptoms, Das and
 his colleagues found doctors at public health centers
 completed less
 than a fifth of essential questions and exams.
 They got the diagnosis right only 8% of the time,
 when they made one at all, and prescribed helpful drugs to
 just 3% of
 patients. Meanwhile, more than two-thirds got unnecessary or
 harmful
 medicine, according to a report published in June by
 the World Bank.
 The results come from a representative sample of 88
 country doctors who ran private clinics in addition to their
 public
 posts in the state of Madhya Pradesh. They did better when
 seeing
 patients privately, but still prescribed appropriate
 treatment to fewer
 than a third.
 In fact, Das and his colleagues found, physicians
 often performed no better than "quacks" without a
 medical degree, who
 are such a common source of healthcare in India that the
 Indian Medical
 Association has an anti-quackery unit.
 While qualified doctors did prescribe more effective
 drugs on average, they also were quicker to administer
 unnecessary
 antibiotics that could have side effects and breed
 resistance.

 The scenario is no better in nearby Bihar state, with
 India's highest infant mortality. According to a report last April in JAMA
 Pediatrics,
  not one of 178 rural health providers offered correct
 therapy to a
 father pretending to seek treatment for a toddler with
 diarrhea.
 In Delhi, the capital, Das's data suggest patients
 get only slightly better care than in the villages, despite
 the fact
 that more urban providers have medical degrees.
 It's not clear if the findings apply to South India,
 or how they compare internationally. But they square with
 widely held
 perceptions in India. While the country has some excellent
 physicians,
 the incompetent ones are so common that they have earned
 their own
 moniker in the medical community: "qualified
 quacks."
 Compared with an unqualified health provider, "a
 qualified quack actually has the ability to do more harm
 because he or
 she would tend to have a smattering of knowledge of a larger
 number" of
 drugs that they might prescribe, says Amit Sengupta, MBBS, a
 public
 health expert with People's Health Movement in
 Delhi.
 Casual Doctors

 The human and economic toll of low-quality healthcare
  is hard to quantify but likely huge. Child deaths remain
 more common in
  India than in Bangladesh and Nepal, where the average
 income is lower.
 Poor people may be hit harder because they are more
 likely to go to the free government clinics, where doctors
 use
 particularly little effort, according to Das and his
 colleagues.
 In a 2008 report in the Journal of Economic
 Perspectives,
  they note that private doctors in Delhi, one of India's
 richest
 regions, were spending just under 4 minutes per patient --
 less than in a
  low-income country such as Tanzania.
 At public clinics, which tend to be understaffed and
 underfunded, the situation was worse. Doctors asked one
 question on
 average -- "What's wrong with you?" -- and
 spent less than 2 minutes per
  patient. Many didn't check the temperature of patients
 who claimed to
 have a fever.
 In one of Das' studies, a pretend patient at a public
  clinic found the doctor outside in his underwear, looking
 drunk. He
 told the patient, who was feigning a heart attack, to go
 away.

 "That's what I mean by low effort," Das
 said.
 Ashish Jha, MD, MPH, from Harvard School of Public
 Health, who is helping to develop a quality agenda for
 Indian government
  hospitals, says the country's hundreds of millions of
 poor sometimes go
  hungry to afford medical care.
 If that care is "really bad quality, there is an
 incredible disservice to that," Jha told MedPage
 Today/VICE.
 Yet the Indian Medical Association's honorary
 secretary general, Krishan Kumar Aggarwal, MD, doesn't
 think his
 profession is to blame.
 "The clinical skills of doctors in India are the
 best in the world," he told MedPage
 Today/VICE, adding that there may be quality problems
 "because of lack of infrastructure in rural
 areas."

 Wild West for Drugs
 Experts say India's drug market, estimated at more
 than $14 billion by research firm IMS Health, is full of
 untested and
 dangerous products. As recently as May, researchers reported in the journal PLOS
 Medicine that "large numbers of unapproved
 formulations are available" in India and "should
 be banned immediately."
 Three years ago a Parliamentary probe accused the
 country's main drug regulator, the Central Drugs
 Standard Control
 Organization, of colluding with pharmaceutical companies and
 medical
 experts to approve medicines without adequate scientific
 scrutiny.
 State authorities too have licensed myriad
 combinations of individually approved drugs without proof
 that the new
 products are safe and effective.

 Take cough and cold medicines. According to a 2010 report in the journal
 Fundamental
 & Clinical Pharmacology,
  more than 1,300 such products were on sale in India in
 2007. Nearly all
  were drug cocktails, with up to 21 active ingredients in a
 single
 product. Many included medicines with opposing effects, and
 27 contained
  banned combinations.
 Lack of oversight puts patients at risk. The FDA
 withdrew U.S. approval for the cough syrup Clistin
 Expectorant in 1982
 after determining the formulation was "not ... a
 rational combination"
 and lacked proven effectiveness. Later, one of the
 product's key
 ingredients, carbinoxamine, was linked to 21 baby deaths,
 and the FDA
 pulled other carbinoxamine-containing products from the
 market.
 But Johnson & Johnson continues to sell Clistin
 Expectorant freely in India, where -- like most medications
 -- it is
 available without a prescription.
 In response to questions about this product, Johnson
 & Johnson told MedPage Today/VICE
  by email that patient safety and well-being are its
 "No. 1 priority." A
  spokesman said Clistin Expectorant was approved in India in
 2008 and
 not recommended for children under 2 years, and that the
 issue of
 rationality is decided by each country's
 authorities.
 In 2011, an Indian government expert
 panel
  summed up the situation this way: "The market is
 flooded by irrational,
  nonessential, and even hazardous drugs that waste resources
 and
 compromise health."
 India recently promised to beef up its regulatory
 efforts and has taken steps toward weeding out unproven drug

 combinations. But it's a tall order, because no one has
 an inventory of
 all the products being sold, according to Urmila Thatte, MD,
 PhD, of
 Seth GS Medical College in Mumbai, who has worked with the
 government on
  the issue.
 Adding to the confusion, a single medication may be
 sold under hundreds of brand names, or different medications
 may carry
 the same name.
 Physicians often don't know the active ingredients in
 the products they administer, experts say. One prescription
 reviewed by MedPage Today/VICE
  contained two different brands of nimesulide, a
 controversial pain drug
  linked to severe liver damage. In this case, a pharmacist
 caught the
 error before the patient began double-dosing.
 Gifts and other incentives from drug reps may
 increase the temptation to prescribe unwarranted treatment,
 says Pijus
 Sarkar, MD, PhD, a former drug regulator of the state of
 West Bengal and
  editor of an independent bulletin on rational medicine.
 In Sarkar's view, cleaning up the drug market is a
 safer bet than changing the behavior of India's nearly
 one million
 medics. "Training the doctors on rationality is like
 trying to
 straighten the tail of a street dog," he says.
 Next: A rough road to physician
 accountability

 To unsubscribe from this list please goto http://www.simplelists.com/confirm.php?u=NHjTOFnRCWu2ZFxgMb32DtGIegnxCqXy